De-Wei Lai | Microbiology | Best Scholar Award

Prof. Dr. De-Wei Lai | Microbiology | Best Scholar Award

Associate Researcher at Taichung Veterans General Hospital, Taiwan

Dr. De-Wei Lai is an accomplished Associate Researcher at the Department of Medical Research, Taichung Veterans General Hospital, Taiwan. With a strong foundation in applied chemistry and immunology, he has dedicated his career to unraveling the complexities of regulatory T cells in diverse pathological conditions. Dr. Lai’s research spans autoimmunity, regenerative medicine, and the tumor microenvironment, with a focus on innovative immunotherapeutic strategies. His expertise integrates modern molecular techniques with natural extracts and traditional Chinese medicine, aiming to develop novel diagnostic and therapeutic solutions. With over 19 SCI/SCIE-indexed publications, 27 editorial appointments, and 16 awards, Dr. Lai has established himself as a leading voice in immunological research. His work, characterized by precision and translational potential, continues to shape the future of immunotherapy.

Professional Profile

Education

Dr. De-Wei Lai completed his undergraduate studies in Applied Chemistry at National Pingtung University, where he developed a deep interest in cellular metabolism and biochemical signaling pathways. He later pursued a Ph.D. in Immunology, focusing on the molecular mechanisms underlying diabetic retinopathy, which culminated in a groundbreaking publication in Circulation Research. His academic journey is marked by excellence in understanding complex immunological pathways and leveraging this knowledge for practical medical applications.

Professional Experience

Dr. Lai began his research career in 2019 at Chang Bing Show Chwan Memorial Hospital, where he studied the isolation, cultivation, and functional analysis of regulatory T cells (Tregs). His work laid the foundation for significant advancements in immunotherapy. In 2024, he joined Taichung Veterans General Hospital, where he expanded his focus to include molecular mechanisms of Tregs in autoimmune diseases, regenerative medicine, and tumor microenvironments. Throughout his career, Dr. Lai has consistently contributed to high-impact research, addressing critical gaps in clinical immunology and advancing innovative therapeutic strategies.

Research Interests

Dr. Lai’s research interests lie at the intersection of immunotherapy, molecular biology, and regenerative medicine. His laboratory explores the molecular mechanisms of regulatory T cells in autoimmune diseases, age-related degenerative conditions, and cancer. Recently, Dr. Lai has extended his work to study the potential of natural extracts, traditional Chinese medicine, and metal-organic nanoparticles as modulators of the immune system. By integrating experimental models with clinical big data, his research aims to develop novel diagnostic tools and immunotherapeutic strategies that address pressing medical challenges.

Research Skills

Dr. Lai possesses a robust skill set in immunological research and molecular biology. His expertise includes regulatory T cell isolation and expansion, animal model development for autoimmune diseases, and the study of tumor microenvironments. He is proficient in advanced techniques such as flow cytometry, immunohistochemistry, and molecular signaling analysis. His interdisciplinary approach also incorporates the evaluation of natural compounds and nanoparticles for therapeutic applications. With strong analytical skills and an eye for innovation, Dr. Lai excels in bridging basic research with translational medicine.

Awards and Honors

Dr. Lai’s contributions to immunological research have been widely recognized. He has received 16 awards and recognitions, highlighting his impact in both academic and clinical settings. These honors reflect his groundbreaking discoveries in T cell biology, innovative therapeutic approaches, and commitment to advancing immunotherapy. His editorial appointments in 27 journals and conferences further underscore his standing in the scientific community as a trusted authority in immunological research. Dr. Lai’s dedication to addressing clinical challenges continues to earn him accolades and inspire future research efforts.

Conclusion

Dr. De-Wei Lai is an excellent candidate for the Best Scholar Award due to his exceptional research achievements, dedication to addressing clinical challenges, and innovative approach to immunotherapy. While he excels in academic publication and editorial roles, areas like project leadership, patents, and international collaborations offer room for growth. Overall, his contributions to immunology and translational medicine make him a strong contender for this recognition.

Publications Top Notes

  • Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain‐mediated C/EBP β and NF κ B cleavage
    • Authors: SM Wu, WY Lin, CC Shen, HC Pan, W Keh‐Bin, YC Chen, YJ Jan, DW Lai, …
    • Journal: Journal of Pineal Research, 60 (2), 142-154
    • Year: 2016
    • Citations: 98
  • Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress, and inhibiting epithelial-to-mesenchymal transition
    • Authors: SH Liu, WJ Lee, DW Lai, SM Wu, CY Liu, HR Tien, CS Chiu, YC Peng, …
    • Journal: Molecular Oncology, 9 (4), 834-849
    • Year: 2015
    • Citations: 64
  • Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model
    • Authors: HC Pan, DW Lai, KH Lan, CC Shen, SM Wu, CS Chiu, KB Wang, …
    • Journal: Carcinogenesis, 34 (11), 2568-2579
    • Year: 2013
    • Citations: 45
  • Aryl hydrocarbon receptor deficiency attenuates oxidative stress-related mesangial cell activation and macrophage infiltration and extracellular matrix accumulation in diabetic nephropathy
    • Authors: WJ Lee, SH Liu, CK Chiang, SY Lin, KW Liang, CH Chen, HR Tien, …
    • Journal: Antioxidants & Redox Signaling, 24 (4), 217-231
    • Year: 2016
    • Citations: 44
  • The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination
    • Authors: DW Lai, SH Liu, AI Karlsson, WJ Lee, KB Wang, YC Chen, CC Shen, …
    • Journal: Oncotarget, 5 (17), 7788
    • Year: 2014
    • Citations: 43
  • Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways
    • Authors: CS Chiu, CH Tsai, MS Hsieh, SC Tsai, YJ Jan, WY Lin, DW Lai, SM Wu, …
    • Journal: Cancer Letters, 442, 113-125
    • Year: 2019
    • Citations: 42
  • TPL2 (therapeutic targeting tumor progression locus-2)/ATF4 (activating transcription factor-4)/SDF1α (chemokine stromal cell-derived factor-α) axis suppresses diabetic retinopathy
    • Authors: DW Lai, KH Lin, WHH Sheu, MR Lee, CY Chen, WJ Lee, YW Hung, …
    • Journal: Circulation Research, 121 (6), e37-e52
    • Year: 2017
    • Citations: 37
  • Attenuation of in vitro and in vivo melanin synthesis using a Chinese herbal medicine through the inhibition of tyrosinase activity
    • Authors: SC Liu, ML Sheu, YC Tsai, YC Lin, CW Chang, DW Lai
    • Journal: Phytomedicine, 95, 153876
    • Year: 2022
    • Citations: 22
  • Melatonin protects retinal integrity through mediated immune homeostasis in the sodium iodate-induced mouse model of age-related macular degeneration
    • Authors: LC Ku, ML Sheu, HH Cheng, CY Lee, YC Tsai, CY Tsai, KH Lin, LC Lai, …
    • Journal: Biomedicine & Pharmacotherapy, 161, 114476
    • Year: 2023
    • Citations: 10
  • AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression
    • Authors: HH Cheng, L Hung‐Ke, ML Sheu, CY Lee, YC Tsai, DW Lai
    • Journal: Immunology, 168 (4), 654-670
    • Year: 2023
    • Citations: 8

 

Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Dr. Hilal Ünsal | Immunology and Microbiology | Best Researcher Award

Hacettepe University Faculty of Medicine, Department of Pediatric Immunology and Allergy at Hacettepe University Faculty of Medicine, Turkey

Dr. Hilal Ünsal is a distinguished pediatric allergist and clinical immunologist specializing in the diagnosis and management of allergies and immunodeficiencies in children. With extensive training and clinical experience, Dr. Ünsal has become a prominent figure in the field of pediatric allergy, contributing significantly to both clinical practice and research. Currently pursuing advanced studies in Pediatric Allergy and Clinical Immunology at Hacettepe University, she combines her clinical expertise with a strong research background, particularly in primary immunodeficiencies, food allergies, and asthma. Her work has been published in several reputable journals, and she is an active participant in international conferences, reflecting her commitment to advancing medical knowledge and improving patient outcomes.

Professional Profile

Education

Dr. Ünsal earned her Medical Degree from Gazi University, Faculty of Medicine in 2012, where she graduated as an honor student. She then pursued a residency in pediatrics at Health Sciences University Dr. Sami Ulus Maternity, Child Health and Diseases Training and Research Hospital, completing her training in 2018. Currently, she is completing a Clinical Fellowship in Pediatric Allergy and Clinical Immunology at Hacettepe University, a program that is enhancing her expertise in the immunologic aspects of pediatric diseases. Dr. Ünsal’s academic path reflects her dedication to continuous learning and professional growth in the medical field.

Professional Experience

Dr. Ünsal’s professional journey has been centered on pediatric allergy and immunology. After completing her medical education and residency, she further honed her skills in pediatric immunology during her fellowship at Hacettepe University, one of Turkey’s leading medical institutions. Over the years, Dr. Ünsal has actively contributed to the diagnosis and management of pediatric allergies, asthma, and immunodeficiencies, working in various clinical settings. Her experience spans the diagnosis of IgE-mediated food allergies, asthma exacerbations, and immunodeficiencies, as well as advanced research in these areas. She has gained a reputation for her meticulous approach to clinical research and patient care.

Research Interests

Dr. Ünsal’s research focuses on the intricate relationships between primary immunodeficiencies, genetics, and pediatric allergies. Her specific interests include food allergies, drug allergies, allergic rhinitis, and asthma, with a strong emphasis on understanding the genetic and immunological factors contributing to these conditions in children. She is particularly dedicated to identifying novel allergens and improving diagnostic methods for food allergies, as well as exploring the role of oxidative stress in asthma. Through her research, Dr. Ünsal aims to improve the quality of life for children suffering from these conditions by enhancing early diagnosis, treatment strategies, and prevention methods.

Research Skills

Dr. Ünsal has developed robust research skills, particularly in the areas of biostatistics, immunological testing, and clinical research methodologies. She is proficient in using SPSS for data analysis, enabling her to conduct rigorous statistical evaluations of her research data. Her research skills are further enhanced by her involvement in multiple projects on food allergies, asthma, and immunodeficiencies. Dr. Ünsal’s expertise in interpreting complex immunological data, along with her ability to work with diverse patient populations, has allowed her to contribute to significant studies in her field. Her active participation in both clinical and experimental research ensures that her work remains at the forefront of pediatric allergy and immunology.

Awards and Honors

Dr. Ünsal’s academic and research excellence has been recognized by her peers and academic institutions. As an honor student at Gazi University, she demonstrated early promise in her medical career. Her ongoing contributions to the field of pediatric allergy and immunology have earned her opportunities to present at numerous prestigious conferences, including the European Academy of Allergy and Clinical Immunology (EAACI) Congress and the World Allergy Congress. Additionally, her research has been published in well-regarded journals such as Pediatric Allergy and Immunology and Turkish Journal of Medical Sciences, which highlights her commitment to advancing knowledge in her field.

Conclusion

Dr. Hilal Ünsal is highly deserving of the Best Researcher Award based on her extensive body of work, leadership in research, and active participation in international conferences. Her expertise in pediatric immunology and allergy is well-documented, and her ongoing research in immunodeficiencies and food allergies is crucial for advancing clinical practice in these areas. While further strengthening her clinical impact and broadening her research funding could enhance her profile, her current contributions to the field place her as a prominent figure in her discipline. Dr. Ünsal is well-positioned for continued excellence in research, making her an excellent candidate for this prestigious award

Publication Top Notes

  1. Title: The treatment journey of children with moderate to severe atopic dermatitis in Türkiye: unmet needs
    • Authors: İlgün Gürel, D., Ünsal, H., Soyak Aytekin, E., Ersoy Evans, S., Şekerel, B.E.
    • Year: 2024
  2. Title: A large single-center cohort of bare lymphocyte syndrome: Immunological and genetic features in Turkey
    • Authors: Ünsal, H., Caka, C., Bildik, H.N., Tezcan, İ., Çağdaş, D.
    • Year: 2024
    • Citations: 2
  3. Title: Cupressus arizonica: an emerging aeroallergen for East Mediterranean children
    • Authors: Ünsal, H., Şahiner, Ü.M., Soyer, Ö., Şekerel, B.E.
    • Year: 2023
  4. Title: Phenotypes of persistent hen’s egg allergy in children and adolescents
    • Authors: Ünsal, H., Dal, S.T., Akarsu, A., Soyer, Ö., Şekerel, B.E.
    • Year: 2023
    • Citations: 2
  5. Title: Obesity is a risk factor for decrease in lung function after COVID-19 infection in children with asthma
    • Authors: Soyak Aytekin, E., Sahiner, U.M., Tuten Dal, S., Sekerel, B.E., Soyer, O.
    • Year: 2022
    • Citations: 9
  6. Title: IgE mediated legume allergy in east Mediterranean children: A reflection of multiple food allergies
    • Authors: Soyak Aytekin, E., Unsal, H., Sahiner, U.M., Soyer, O., Sekerel, B.E.
    • Year: 2022
    • Citations: 4
  7. Title: Comparison of miRNA expression in patients with seasonal and perennial allergic rhinitis and non-atopic asthma
    • Authors: Tunçer, F., Şahiner, Ü.M., Ocak, M., Şekerel, B.E., Birben, E.
    • Year: 2022
    • Citations: 4
  8. Title: Clinical Validation of the Spirohome Clinic Ultrasonic Spirometer in Child and Adolescent Patients
    • Authors: Sekerel, B.E., Unsal, H., Sahiner, U.M., Karakaya, G., Kalyoncu, A.F.
    • Year: 2022
    • Citations: 5
  9. Title: Food allergy management has been negatively impacted during the COVID-19 pandemic
    • Authors: Soyak Aytekin, E., Tüten Dal, S., Ünsal, H., Soyer, Ö., Şekerel, B.E.
    • Year: 2021
    • Citations: 2
  10. Title: Allergic reactions against COVID-19 vaccines
    • Authors: Ünsal, H., Şekerel, B.E., Şahiner, Ü.M.
    • Year: 2021
    • Citations: 4

 

Fahimeh Alizadeh | Immunology and Microbiology | Best Researcher Award

Assoc Prof Dr. Fahimeh Alizadeh | Immunology and Microbiology | Best Researcher Award

Supervisor of Islamic Azad University, Iran.

Dr. Fahimeh Alizadeh is an accomplished researcher and educator in the field of microbial biotechnology, currently serving as an Associate Professor at the Department of Biology, Islamic Azad University, Gachsaran, Iran. With over two decades of experience in academia, she has previously held roles at the Yasooj Branch of Islamic Azad University, including positions as Head of the Department of Biology and Paramedical Sciences. Dr. Alizadeh’s research expertise encompasses microbial interactions, nanoparticle applications, and antifungal and antibacterial agents. Her significant contributions include research on the molecular mechanisms of Candida species, nanoparticle-based therapies, and biofilm formation. She has secured notable research grants and published extensively in high-impact journals. Dr. Alizadeh holds a Ph.D. from the University of Putra Malaysia and a Post-Doctoral fellowship from the same institution. Her extensive publication record and leadership in scientific research underscore her prominent role in her field.

Profile
Education

Fahimeh Alizadeh holds a robust academic background in microbiology and microbial biotechnology. She completed her Bachelor’s and Master’s degrees in Biology-Microbiology at Islamic Azad University, Iran, where she laid the foundation for her specialization. She further advanced her expertise by earning a Ph.D. in Microbial Biotechnology from the University of Putra Malaysia, Malaysia, where she delved into advanced research techniques and microbial interactions. Dr. Alizadeh continued her scholarly journey with a post-doctoral fellowship at the same institution, focusing on cutting-edge microbial biotechnology. Her educational trajectory reflects a strong commitment to understanding microbial systems and advancing biotechnological applications, equipping her with comprehensive knowledge and research capabilities in her field.

Professional Experience

Dr. Fahimeh Alizadeh has an extensive academic and research career, currently serving as an Associate Professor in the Department of Biology at Gachsaran Branch, Islamic Azad University, Iran since 2023. Prior to this role, she was an Assistant Professor at Yasooj Branch, Islamic Azad University from 2000 to 2023, where she also held leadership positions as Head of the Department of Biology and Head of the Department of Paramedical Sciences at different intervals. Her teaching expertise spans across various subjects, including Biology, Medical Biochemistry, Immunology, and Microbiology. Dr. Alizadeh’s research experience is highlighted by her involvement in several significant projects and grants, including studies on microbial interactions, nanoparticles, and antifungal activities. Her contributions to the field are reflected in her numerous journal publications and research grants, underscoring her commitment to advancing scientific knowledge in microbial biotechnology and related disciplines.

Research Interest

Fahimeh Alizadeh’s research interests encompass a wide array of topics in microbial biotechnology and medical microbiology. Her work primarily focuses on exploring molecular mechanisms underlying microbial interactions, particularly involving fungal pathogens such as Candida albicans. She is deeply involved in studying the inhibitory effects of natural compounds and nanoparticles on pathogenic microorganisms and their biofilms. Her research aims to elucidate the molecular targets and mechanisms of antimicrobial agents, including thymol- and carvacrol-loaded nanoparticles, in combating drug-resistant strains and cancer cells. Additionally, Alizadeh investigates the role of transcription factors and signaling molecules in plant-pathogen interactions, emphasizing the defense responses in oil palm against fungal pathogens. Her extensive studies on the molecular and phenotypic characterization of microbial resistance and biofilm formation contribute significantly to the development of novel therapeutic strategies and antimicrobial agents.

Research Skills

Dr. Fahimeh Alizadeh demonstrates exceptional research skills in the field of microbiology and microbial biotechnology. Her expertise encompasses a broad range of techniques and methodologies, including the isolation and characterization of transcription factors, the development of nanoparticles for therapeutic applications, and the study of antifungal and antibacterial properties of natural compounds. Dr. Alizadeh excels in molecular profiling and transcriptomic analysis, employing massive parallel sequencing to investigate gene expression during pathogen interactions. Her research frequently involves complex in vitro and in vivo studies, such as evaluating the inhibitory effects of various compounds on pathogenic microorganisms and cancer cell lines. Her ability to synthesize and analyze data from diverse experimental approaches highlights her proficiency in translating fundamental research into practical applications. This comprehensive skill set underscores her significant contributions to advancing knowledge in microbial biotechnology and therapeutic development.

Awards and Recognition

Dr. Fahimeh Alizadeh has garnered notable recognition for her impactful contributions to microbial biotechnology and her extensive research in the field. She has been acknowledged for her groundbreaking work on the molecular mechanisms of antifungal agents and nanoparticles in combating resistant pathogens. Her research projects, such as the study on thymol- and carvacrol-loaded nanoparticles and Candida species, have significantly advanced the understanding of antifungal resistance mechanisms. Dr. Alizadeh’s publications in prominent journals, including Pharmaceutical Sciences and Applied Biochemistry and Biotechnology, highlight her expertise and commitment to advancing medical and environmental microbiology. Her leadership roles as Head of the Department of Biology at Yasooj Branch and her active involvement in international research projects further demonstrate her excellence in academia. These achievements underscore her significant contributions to science and her esteemed position in the research community.

Conclusion

Fahimeh Alizadeh is a highly qualified candidate for the Research for Best Researcher Award, with extensive experience in academia, significant research contributions, and a strong publication record. Her leadership roles and research projects highlight her expertise and commitment to advancing microbial biotechnology.

Publications Top Notes

  • Anti-cancer activity of secreted aspartyl proteinase protein from Candida tropicalis on human cervical cancer HeLa cells
    • Authors: E.P. Kokhdan, P. Khodavandi, M.H. Ataeyan, A. Khodavandi, A. Zaheri
    • Year: 2024
  • Possible Molecular Targeting of Biofilm-Associated Genes by Nano-Ag in Candida albicans
    • Authors: M.B. Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2024
  • Possibility of intrauterine transmission from mother to fetus/newborn: Systematic review and meta-analysis of diagnostic methods to detect SARS-CoV-2 infection
    • Authors: P. Khodavandi, A. Khodavandi, F. Alizadeh, L. Gholizadeh
    • Year: 2024
    • Citations: 1
  • Hyphae-specific genes: Possible molecular targets for magnetic iron oxide nanoparticles alone and combined with visible light in Candida albicans
    • Authors: P. Khodavandi, A. Hosseini, A. Khodavandi, A. Azizi, M. Gerami
    • Year: 2023
    • Citations: 1
  • Antibacterial and Anti-Biofilm Activities of Microbial Synthesized Silver and Magnetic Iron Oxide Nanoparticles Against Pseudomonas aeruginosa
    • Authors: M.B. Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2023
    • Citations: 3
  • Biofilm-associated genes as potential molecular targets of nano-Fe3O4 in Candida albicans
    • Authors: M. Baghiat Esfahani, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2023
    • Citations: 1
  • Synergistic interaction of fluconazole/ sodium bicarbonate on the inhibition of Candida glabrata phospholipase gene
    • Authors: S.M.K. Hosseini, F. Alizadeh, S. Nouripour-Sisakht, A. Khodavandi
    • Year: 2022
  • Resistance profiling of metallo-betalactamase genes in clinical isolates of Enterobacteriaceae: Emergence of multidrug resistance
    • Authors: H. Alizadeh, A. Khodavandi, F. Alizadeh, N. Bahador
    • Year: 2021
    • Citations: 2
  • Antifungal activity of menthol alone and in combination on growth inhibition and biofilm formation of Candida albicans
    • Authors: N. Norouzi, F. Alizadeh, A. Khodavandi, M. Jahangiri
    • Year: 2021
    • Citations: 15
  • Association between dietary intake and risk of ovarian cancer: a systematic review and meta-analysis
    • Authors: A. Khodavandi, F. Alizadeh, A.F.A. Razis
    • Year: 2021
    • Citations: 28

 

Svetlana Pleskova | Immunology and Microbiology | Best Researcher Award

Prof. Svetlana Pleskova | Immunology and Microbiology | Best Researcher Award

Head of the laboratory of Nizhny Novgorod State University named after N.I. Lobachevsky, Russia.

Professor Svetlana Pleskova, a prominent figure in nanotechnology and biotechnology, currently holds key academic positions at Alekseev Nizhny Novgorod Technical State University and Lobachevsky Nizhny Novgorod State University. She has a robust educational foundation, with a Doctorate from the Alekseev Technical State University and a PhD from the Department of Microbiology and Immunology of the Medical State Academy, both in Nizhni Novgorod. Her professional journey includes leading laboratories, conducting cutting-edge research in atomic force microscopy, and studying the interactions between nanoparticles and blood cells. Svetlana’s research interests encompass septicemia, antibiotic resistance diagnostics, and biocompatibility of advanced nanoparticles. With over 150 publications, numerous awards, and active participation in scientific conferences, she is a distinguished member of the Federation of the Societies of Biochemistry and Molecular Biology and the Federation of Biotechnology. Her contributions to the field are significant and widely recognized.

Professional Profiles:

Education

Svetlana Pleskova holds a Doctorate in Biotechnology, Physical, and Analytical Chemistry (Physiology, Allergology, and Immunology) from Alekseev Technical State University, Nizhni Novgorod, completed between 2007 and 2009. She earned her PhD in Physiology, Allergology, and Immunology from the Department of Microbiology and Immunology at the Medical State Academy in Nizhni Novgorod from 1998 to 2001. Svetlana also holds a Bachelor’s degree in Molecular Biology and Immunology from Lobachevsky Nizhni Novgorod State University, graduating with honors (cum laude) in 1998. Her educational journey began at Medical School in Nizhni Novgorod, where she graduated with honors (cum laude) in 1992.

Professional Experience

Professor Svetlana Pleskova is a distinguished researcher in nanotechnology and biotechnology. Since 2016, she has been a Professor at Alekseev Nizhny Novgorod Technical State University and leads the scanning probe microscopy laboratory at Lobachevsky Nizhny Novgorod State University. Her research focuses on septicemia, septicopiemia, and antibiotic resistance diagnostics. Svetlana previously led the Nanobiotechnology and Atomic Force Microscopy group, focusing on nanoparticle biocompatibility. From 2009 to 2013, she was a Professor and Leading Research Fellow at Nizhny Novgorod Technical State University, researching nanoparticle-blood cell interactions and TiO2-nanofilms. She has also worked under Prof. Solioz in Switzerland and Prof. Lesniewska in France, creating nanopumps and studying cell interactions. Her earlier roles include Associate Professor, Assistant, and Researcher in microbiology, immunology, and biotechnology.

Research Interest

Professor Svetlana Pleskova’s research interests lie at the intersection of nanotechnology, biotechnology, and medical sciences. She focuses on studying septicemia and septicopiemia through advanced microscopy techniques such as atomic force microscopy, scanning ion-conducting microscopy, and scanning electron microscopy. Her work explores the adhesion contacts between endothelial cell receptors and blood cells modified by bacteria and nanoparticles. Additionally, she is dedicated to the development of nanotips for real-time antibiotic resistance diagnostics. Svetlana is also interested in the biocompatibility of nanoparticles, including quantum dots, nanoscale luminophores, and magnetic nanoparticles, as well as the bactericidal properties of TiO2-nanofilms. Her diverse research aims to advance diagnostic and therapeutic approaches in healthcare.

 Award and Honors

Professor Svetlana Pleskova has received numerous awards and honors throughout her distinguished career. She has been recognized with 14 awards and grants, including 6 where she served as the head. Her accolades reflect her significant contributions to the fields of nanotechnology and biotechnology. Svetlana is an esteemed member of the Federation of Societies of Biochemistry and Molecular Biology and the Federation of Biotechnology. Additionally, she serves as a reviewer for the Russian Science Foundation and the Research Institute of FGBNU Rinkc, further highlighting her expertise and influence in her field.

 Research Skills

Professor Svetlana Pleskova possesses extensive research skills in nanotechnology, biotechnology, and molecular biology. She is proficient in atomic force microscopy, scanning ion-conducting microscopy, and scanning electron microscopy, which she utilizes to study septicemia, septicopiemia, and adhesion contacts between endotheliocytes and blood cells. Svetlana has expertise in creating nanotips for real-time diagnostics of antibiotic resistance and developing nanopumps for heavy metals. Her work includes the study of biocompatibility of nanoparticles, quantum dots, nanoscale luminophores, and magnetic nanoparticles. Additionally, she has experience in using ELISA for diagnostics and in the physiological modification of the complement system.

Publications

  1. “Nanomotion of bacteria to determine metabolic profile”
    • Authors: Pleskova, S.N., Lazarenko, E.V., Bezrukov, N.A., Dokukin, M.E., Surodin, S.I.
    • Journal: Nanotechnology and Precision Engineering
    • Year: 2024
    • Citations: 0
  2. “A Study of EA.hy926 Endothelial Cells Using Atomic Force and Scanning Ion Conductance Microscopy”
    • Authors: Pleskova, S.N., Bezrukov, N.A., Gorshkova, E.N., Bobyk, S.Z., Lazarenko, E.V.
    • Journal: Cell and Tissue Biology
    • Year: 2024
    • Citations: 0
  3. “Exploring the Process of Neutrophil Transendothelial Migration Using Scanning Ion-Conductance Microscopy”
    • Authors: Pleskova, S.N., Bezrukov, N.A., Gorshkova, E.N., Bobyk, S.Z., Lazarenko, E.V.
    • Journal: Cells
    • Year: 2023
    • Citations: 1
  4. “ROS Production by a Single Neutrophil Cell and Neutrophil Population upon Bacterial Stimulation”
    • Authors: Pleskova, S.N., Erofeev, A.S., Vaneev, A.N., Bezrukov, N.A., Lazarenko, E.V.
    • Journal: Biomedicines
    • Year: 2023
    • Citations: 0
  5. “A New Method for Express Detection of Antibiotic Resistance”
    • Authors: Pleskova, S.N., Lazarenko, E.V., Sudakova, I.S., Kriukov, R.N., Bezrukov, N.A.
    • Journal: Applied Biochemistry and Microbiology
    • Year: 2023
    • Citations: 2
  6. “Study of EA.hy926 Endothelial Cells by Atomic Force and Scanning Ion-Conductance Microscopy”
    • Authors: Pleskovaa, S.N., Bezrukov, N.A., Gorshkova, E.N., Bobyk, S.Z., Lazarenkoa, E.V.
    • Journal: Tsitologiya
    • Year: 2023
    • Citations: 0
  7. “Differences in bacteria nanomotion profiles and neutrophil nanomotion during phagocytosis”
    • Authors: Pleskova, S.N., Lazarenko, E.V., Bezrukov, N.A., Boryakov, A.V., Kriukov, R.N.
    • Journal: Frontiers in Microbiology
    • Year: 2023
    • Citations: 4
  8. “Staphylococcus aureus Causes the Arrest of Neutrophils in the Bloodstream in a Septicemia Model”
    • Authors: Pleskova, S.N., Bobyk, S.Z., Kriukov, R.N., Gorshkova, E.N., Bezrukov, N.A.
    • Journal: Microorganisms
    • Year: 2022
    • Citations: 1
  9. “High-Resolution Scanning Ion-Conductance Microscopy for the Study of Blood Cell Morphology and Rigidity”
    • Authors: Bezrukov, N.A., Pleskova, S.N., Bobyk, S.Z., Boryakov, A.V.
    • Journal: Opera Medica et Physiologica
    • Year: 2022
    • Citations: 0
  10. “Nanovibrations of Atomic Force Microscope Cantilevers as a System for Real Time Detection of Antibiotic Resistance in Bacteria”
    • Authors: Pleskova, S.N., Fomichev, O.I., Kriukov, R.N., Sudakova, I.S.
    • Journal: Biophysics (Russian Federation)
    • Year: 2021
    • Citations: 2